CTX310
LIVE

Serial Number

97461217

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

First Use Date

Nov 17, 2023

Filing Date

Jun 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CTX310 Trademark

Serial Number: 97461217 • Registration: 8005333

CTX310 is a trademark filed by CRISPR Therapeutics AG on June 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

June 16, 2022

Registration Date

October 28, 2025

First Use Anywhere

November 17, 2023

First Use in Commerce

November 17, 2023

Published for Opposition

April 23, 2024

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 9, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 9, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 12, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2025 CRFA
ASSIGNED TO LIE
May 15, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 3, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 13, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 11, 2025 AITU
USE AMENDMENT FILED
Oct 28, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 28, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 27, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 2, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 2, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 2, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 10, 2023 TROA
ASSIGNED TO EXAMINER
Jul 3, 2023 DOCK
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 11, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 11, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2022 NWOS
NEW APPLICATION ENTERED
Jun 20, 2022 NWAP